MEMPHASYS LTD.
No trades
−0.001841 USD
−3.31 M USD
2.43 K USD
1.73 B
About Memphasys Ltd
Sector
Industry
Website
Headquarters
Sydney
Founded
2006
IPO date
May 14, 2007
Identifiers
2
ISIN AU000000MEM5
Memphasys Ltd. is a life sciences company, which engages in the development and commercialization of novel reproduction and fertility solutions for humans and animals. The company was founded in 2006 and is headquartered in Sydney, Australia.
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange MEMPHASYS LTD. stocks are traded under the ticker MPHSF.
Yes, you can track MEMPHASYS LTD. financials in yearly and quarterly reports right on TradingView.
MPHSF net income for the last half-year is −1.36 M USD, while the previous report showed −1.84 M USD of net income which accounts for 25.77% change. Track more MEMPHASYS LTD. financial stats to get the full picture.
No, MPHSF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEMPHASYS LTD. EBITDA is −2.25 M USD, and current EBITDA margin is −92.41 K%. See more stats in MEMPHASYS LTD. financial statements.
Like other stocks, MPHSF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEMPHASYS LTD. stock right from TradingView charts — choose your broker and connect to your account.